Results 181 to 190 of about 41,565 (267)

A potential of serum anti-C1P IgG antibodies as biomarkers in differential diagnosis of relapsing-remitting multiple sclerosis. [PDF]

Sci Rep
Chojdak-Lukasiewicz J, Jakubiak-Augustyn A, Szulc ZM, Gubernator J, Blazej P, Pokryszko-Dragan A, Budrewicz S, Podbielska M.   +7 more
europepmc   +1 more source

Twenty-Four-Month Real-World Outcomes of Ofatumumab in Relapsing-Remitting Multiple Sclerosis: A Multicenter Retrospective Cohort Study. [PDF]

J Clin Med
Galus W, Kiełbowicz-Hołysz M, Siuda J, Gajewska G, Lasek-Bal A, Puz P.   +5 more
europepmc   +1 more source

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China. [PDF]

BMC Neurol
Tan H, Zhou L, Gao Y, Zhao C, Lu C, Dong Q, ZhangBao J, Quan C.   +7 more
europepmc   +1 more source

Functional Training Mitigates Reduced Circulating Indole-3-Lactate Levels in Persons With Relapsing-Remitting Multiple Sclerosis. [PDF]

Acta Physiol (Oxf)
Wences Chirino T, Adammek F, Belen S, Winker M, Proschinger S, Rademacher A, Schlagheck ML, Schenk A, Kupjetz M, Walzik D, Warnke C, Reuter M, Rosenberger F, Meyer T, McCann A, Ueland PM, Joisten N, Zimmer P.   +17 more
europepmc   +1 more source

Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease Knowledge. [PDF]

J Pers Med
Pérez-Sempere Á, García-Arcelay E, Pérez JC, Candeliere-Merlicco A, Orviz A, Martín-Martínez J, Piñar-Morales R, Álvarez-Rodríguez E, Pacheco-Cortegana EM, Borrega L, Casanova I, Caminero AB, Sánchez-Menoyo JL, Gómez-Gutiérrez M, Carmona O, Calles C, Hernández MÁ, López-Muñoz P, Bakdache F, Monreal E, González-Suárez I, Maurino J.   +21 more
europepmc   +1 more source

Effectiveness and Safety of Rituximab in Filipino Patients With Relapsing-Remitting Multiple Sclerosis: A Real-World Retrospective Cohort Study in a Resource-Limited Setting. [PDF]

Cureus
Co APC, De la Paz FGE, Aninang MT, Del Mundo MES, Nobleza CMN, Damian LF.   +5 more
europepmc   +1 more source

Myelin-specific IL2 + T-cells are associated with last occurring relapse severity in relapsing-remitting multiple sclerosis. [PDF]

Sci Rep
Zilkha-Falb R, Drori T, Shwartz K, Gurevich M.   +3 more
europepmc   +1 more source

Association of the along‑perivascular space (ALPS) index and white matter volume with cognitive dysfunction in relapsing‑remitting multiple sclerosis patients. [PDF]

BMC Neurol
Song Y, Zhao H, Wu Q, Xie S, He J, Bai R, Wang S, Gao Y.   +7 more
europepmc   +1 more source

Video Head Impulse Testing in Relapsing Remitting Multiple Sclerosis: Evaluation of Canal Gains, Asymmetry, and Corrective Saccades with Cerebellar Lesions. [PDF]

J Otol
Tahir E, Küçüköner A, Uştu EK, Şen S, Terzi M.   +4 more
europepmc   +1 more source